Many everyday symptoms are inconsequential. You have a poor night’s sleep to thank for your bloodshot eyes, or a new lotion ...

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Don’t let winter ailments slow you down. Discover how understanding your symptoms can lead to powerful relief while embracing ...

Once again, a new strain of COVID has hit the country, and that includes Rhode Island. According to the Centers for Disease ...

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

While respiratory syncytial virus (RSV) typically causes mild symptoms in adults, the virus can be life-threatening for infants. The seasonal virus is the most common cause of lower respiratory tract ...

SARS-CoV-2 infection in children and adolescents increases risk for cardiovascular disease, compared with uninfected individuals.